1887
Surveillance Open Access
Like 0

Abstract

Introduction

Meticillin-resistant (MRSA) is a major cause of healthcare-associated infections.

Aim

We describe MRSA colonisation/infection and bacteraemia rate trends in Dutch–German border region hospitals (NL–DE-BRH) in 2012–16.

Methods

All 42 NL–DE BRH (8 NL-BRH, 34 DE-BRH) within the cross-border network EurSafety Health-net provided surveillance data (on average ca 620,000 annual hospital admissions, of these 68.0% in Germany). Guidelines defining risk for MRSA colonisation/infection were reviewed. MRSA-related parameters and healthcare utilisation indicators were derived. Medians over the study period were compared between NL- and DE-BRH.

Results

Measures for MRSA cases were similar in both countries, however defining patients at risk for MRSA differed. The rate of nasopharyngeal MRSA screening swabs was 14 times higher in DE-BRH than in NL-BRH (42.3 vs 3.0/100 inpatients; p < 0.0001). The MRSA incidence was over seven times higher in DE-BRH than in NL-BRH (1.04 vs 0.14/100 inpatients; p < 0.0001). The nosocomial MRSA incidence-density was higher in DE-BRH than in NL-BRH (0.09 vs 0.03/1,000 patient days; p = 0.0002) and decreased significantly in DE-BRH (p = 0.0184) during the study. The rate of MRSA isolates from blood per 100,000 patient days was almost six times higher in DE-BRH than in NL-BRH (1.55 vs 0.26; p = 0.0041). The patients had longer hospital stays in DE-BRH than in NL-BRH (6.8 vs 4.9; p < 0.0001). DE-BRH catchment area inhabitants appeared to be more frequently hospitalised than their Dutch counterparts.

Conclusions

Ongoing IPC efforts allowed MRSA reduction in DE-BRH. Besides IPC, other local factors, including healthcare systems, could influence MRSA epidemiology.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2019.24.15.1800244
2019-04-11
2019-04-22
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2019.24.15.1800244
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/24/15/eurosurv-24-15-1.html?itemId=/content/10.2807/1560-7917.ES.2019.24.15.1800244&mimeType=html&fmt=ahah

References

  1. Poljak M, Akova M, Friedrich AW, Rodríguez-Baño J, Sanguinetti M, Tacconelli E, et al. ESCMID-an international Europe-based society committed to fostering cross-border collaboration and education to improve patient care. Clin Microbiol Infect. 2018;24(1):1-2.  https://doi.org/10.1016/j.cmi.2017.05.024  PMID: 28583741 
  2. Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56-66.  https://doi.org/10.1016/S1473-3099(18)30605-4  PMID: 30409683 
  3. European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance surveillance in Europe 2016. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2017. Available from: https://ecdc.europa.eu/sites/portal/files/documents/AMR-surveillance-Europe-2016.pdf
  4. European Centre for Disease Prevention and Control (ECDC). ECDC, EFSA and EMA Joint Scientific Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food-producing animals. EFSA J. 2017;15(10):5017.
  5. van Cleef BAGL, Kluytmans JAJW, van Benthem BHB, Haenen A, Monen J, Daniels-Haardt I, et al. Cross border comparison of MRSA bacteraemia between The Netherlands and North Rhine-Westphalia (Germany): a cross-sectional study. PLoS One. 2012;7(8):e42787.  https://doi.org/10.1371/journal.pone.0042787  PMID: 22880109 
  6. Köck R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, et al. Systematic literature analysis and review of targeted preventive measures to limit healthcare-associated infections by meticillin-resistant Staphylococcus aureus. Euro Surveill. 2014;19(29):23-49.  https://doi.org/10.2807/1560-7917.ES2014.19.29.20860  PMID: 25080142 
  7. Sai N, Laurent C, Strale H, Denis O, Byl B. Efficacy of the decolonization of methicillin-resistant Staphylococcus aureus carriers in clinical practice. Antimicrob Resist Infect Control. 2015;4(56):56.  https://doi.org/10.1186/s13756-015-0096-x  PMID: 26688720 
  8. Sassmannshausen R, Deurenberg RH, Köck R, Hendrix R, Jurke A, Rossen JWA, et al. MRSA Prevalence and Associated Risk Factors among Health-Care Workers in Non-outbreak Situations in the Dutch-German EUREGIO. Front Microbiol. 2016;7(1273):1273.  https://doi.org/10.3389/fmicb.2016.01273  PMID: 27597843 
  9. Dik JW, Sinha B, Friedrich AW, Lo-Ten-Foe JR, Hendrix R, Köck R, et al. Cross-border comparison of antibiotic prescriptions among children and adolescents between the north of the Netherlands and the north-west of Germany. Antimicrob Resist Infect Control. 2016;5(1):14.  https://doi.org/10.1186/s13756-016-0113-8  PMID: 27096086 
  10. Commission for Hospital Hygiene and Infection Prevention at Robert Koch-Institute. Empfehlungen zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in medizinischen und pflegerischen Einrichtungen. [Recommendations for prevention and control of methicillin-resistant Staphylococcus aureus (MRSA) in medical and nursing facilities]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57(6):695-732. German.  https://doi.org/10.1007/s00103-014-1980-x 
  11. Commission for Hospital Hygiene and Infection Prevention at Robert Koch-Institute. Empfehlungen zur Prävention und Kontrolle von Methicillinresistenten Staphylococcus aureus-Stämmen (MRSA) in medizinischen und pflegerischen Einrichtungen. [Recommendations for the prevention and control of methicillin-resistant Staphylococcus aureus isolates (MRSA) in hospitals and other healthcare facilities]. GMS Krankenhhyg Interdiszip. 2009;4(1):Doc01. PMID: 20204101 
  12. Friedrich AW, Daniels-Haardt I, Köck R, Verhoeven F, Mellmann A, Harmsen D, et al. EUREGIO MRSA-net Twente/Münsterland--a Dutch-German cross-border network for the prevention and control of infections caused by methicillin-resistant Staphylococcus aureus. Euro Surveill. 2008;13(35):18965.  https://doi.org/10.2807/ese.13.35.18965-en  PMID: 18761882 
  13. Ciccolini M, Donker T, Köck R, Mielke M, Hendrix R, Jurke A, et al. Infection prevention in a connected world: the case for a regional approach. Int J Med Microbiol. 2013;303(6-7):380-7.  https://doi.org/10.1016/j.ijmm.2013.02.003  PMID: 23499307 
  14. Souverein D, Houtman P, Euser SM, Herpers BL, Kluytmans J, Den Boer JW. Costs and Benefits Associated with the MRSA Search and Destroy Policy in a Hospital in the Region Kennemerland, The Netherlands. PLoS One. 2016;11(2):e0148175.  https://doi.org/10.1371/journal.pone.0148175  PMID: 26849655 
  15. Jurke A, Köck R, Becker K, Thole S, Hendrix R, Rossen J, et al. Reduction of the nosocomial meticillin-resistant Staphylococcus aureus incidence density by a region-wide search and follow-strategy in forty German hospitals of the EUREGIO, 2009 to 2011. Euro Surveill. 2013;18(36):20579.  https://doi.org/10.2807/1560-7917.ES2013.18.36.20579  PMID: 24079380 
  16. Eurostat. Nomenclature of territorial units for statistics (NUTS); National structures (EU). Eurostat; 2018. Available from: https://ec.europa.eu/eurostat/web/nuts/national-structures-eu
  17. Eurostat. Population density by NUTS 3 region. Eurostat: 2018. Available from: https://ec.europa.eu/eurostat/web/products-datasets/product?code=demo_r_d3dens
  18. Werkgroep Infectiepreventie (WIP). Meticilline-resistente Staphylococcus aureus (MRSA) – Ziekenhuizen [ Meticilline-resistente Staphylococcus aureus (MRSA) - hospitals]. Leiden; WIP; 2012. Dutch. Available from: http://www.rivm.nl/dsresource?objectid=3f054354-ff4a-43ef-91f9-7c6f0417be95&type=org&disposition=inline
  19. Nederlandse Vereniging voor Medische Microbiologie (NVMM). NVvMM —richtlijn [Dutch Society for Medical Microbiology—Guideline: Laboratory detection of highly resistant microorganisms (HRMO) version 2.0]. Leeuwarden; NVMM; 2012. [Accessed 03 Feb 2019]. Available from: https://www.nvmm.nl/media/1051/2012_hrmo_mrsa_esbl.pdf.
  20. Surveillance NI. MRSA-KISS-Protocoll-2016; MRSA KISS Reference data 2016. [Accessed 03 Feb 2019]. Available from: https://www.nrz-hygiene.de/surveillance/kiss/mrsa-kiss/archiv/ 2017.
  21. European Commission. Communication from the Commission to the European Parliament and the Council. Action plan against the rising threats from Antimicrobial Resistance. Brüssel: Publications Office of the European Union; 2011. Available from: https://www.eumonitor.eu/9353000/1/j4nvke1fm2yd1u0_j9vvik7m1c3gyxp/vkcwedxv7dzy/v=s7z/f=/com(2011)748_en.pdf
  22. (PEG) P-E-GfC. GERMAP 2015 – Bericht über den Antibiotikaverbrauch und die Verbreitung von Antibiotikaresistenzen in der Human- und Veterinärmedizin in Deutschland. Rheinbach: Antiinfectives Intelligence; 2016. Report No.: 978-3-9818383-0-5. Available from: http://www.p-e-g.org/econtext/germap
  23. SWAB. NethMap 2017, Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in The Netherlands in 2016. MARAN 2017, Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in the Netherlands in 2016. Bergen; 2019. Available from: https://www.rivm.nl/bibliotheek/rapporten/2017-0056.pdf
  24. van der Zee A, Hendriks WD, Roorda L, Ossewaarde JM, Buitenwerf J. Review of a major epidemic of methicillin-resistant Staphylococcus aureus: the costs of screening and consequences of outbreak management. Am J Infect Control. 2013;41(3):204-9.  https://doi.org/10.1016/j.ajic.2012.02.033  PMID: 22921104 
  25. Köck R, Werner P, Friedrich AW, Fegeler C, Becker KPrevalence of Multiresistant Microorganisms (PMM) Study GroupPrevalence of Multiresistant Microorganisms PMM Study Group. Persistence of nasal colonization with human pathogenic bacteria and associated antimicrobial resistance in the German general population. New Microbes New Infect. 2015;9:24-34.  https://doi.org/10.1016/j.nmni.2015.11.004  PMID: 26862431 
  26. Weterings V, Veenemans J, van Rijen M, Kluytmans J. Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus in patients at hospital admission in the Netherlands, 2010 - 2017: an observational study. Clin Microbiol Infect. 2019;S1198-743X(19)30114-4.  https://doi.org/10.1016/j.cmi.2019.03.012  PMID: 30928560 
  27. Köck R, Schaumburg F, Mellmann A, Köksal M, Jurke A, Becker K, et al. Livestock-associated methicillin-resistant Staphylococcus aureus (MRSA) as causes of human infection and colonization in Germany. PLoS One. 2013;8(2):e55040.  https://doi.org/10.1371/journal.pone.0055040  PMID: 23418434 
  28. Schaumburg F, Köck R, Mellmann A, Richter L, Hasenberg F, Kriegeskorte A, et al. study group. Population dynamics among methicillin-resistant Staphylococcus aureus isolates in Germany during a 6-year period. J Clin Microbiol. 2012;50(10):3186-92.  https://doi.org/10.1128/JCM.01174-12  PMID: 22814464 
  29. Köck R, Brakensiek L, Mellmann A, Kipp F, Henderikx M, Harmsen D, et al. Cross-border comparison of the admission prevalence and clonal structure of meticillin-resistant Staphylococcus aureus. J Hosp Infect. 2009;71(4):320-6.  https://doi.org/10.1016/j.jhin.2008.12.001  PMID: 19201056 
  30. Haley RW. Surveillance by objective: a new priority-directed approach to the control of nosocomial infections. The National Foundation for Infectious Diseases lecture. Am J Infect Control. 1985;13(2):78-89.  https://doi.org/10.1016/0196-6553(85)90085-9  PMID: 3846430 
  31. Gastmeier P, Bräuer H, Forster D, Dietz E, Daschner F, Rüden H. A quality management project in 8 selected hospitals to reduce nosocomial infections: a prospective, controlled study. Infect Control Hosp Epidemiol. 2002;23(2):91-7.  https://doi.org/10.1086/502013  PMID: 11893154 
  32. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725-32.  https://doi.org/10.1056/NEJMoa061115  PMID: 17192537 
  33. Robert-Koch-Institute. Surveillance Statistics (Germany). [email protected] 2.0. [Accessed 03 Feb 2019]. Available from: https://survstat.rki.de
  34. Walter J, Haller S, Blank HP, Eckmanns T, Abu Sin M, Hermes J. Incidence of invasive meticillin-resistant Staphylococcus aureus infections in Germany, 2010 to 2014. Euro Surveill. 2015;20(46):30067.  https://doi.org/10.2807/1560-7917.ES.2015.20.46.30067  PMID: 26607355 
  35. Robert-Koch-Institute. Antimicrobial Resistance Surveillance (ARS, Germany). [Accessed 03 Feb 2019]. Available from: https://ars.rki.de
  36. Olearo F, Albrich WC, Vernaz N, Harbarth S, Kronenberg ASwiss Centre For Antibiotic Resistance Anresis. Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014. Swiss Med Wkly. 2016;146:w14339.  https://doi.org/10.4414/smw.2016.14339  PMID: 27631162 
  37. NVMM. Infectieziekten Surveillance Informatie Systeem - Antibiotica Resistentie (ISIS-AR). [Accessed 03 Feb 2019]. Available from: https://www.isis-web.nl
  38. Raupach-Rosin H, Duddeck A, Gehrlich M, Helmke C, Huebner J, Pletz MW, et al. Deficits in knowledge, attitude, and practice towards blood culture sampling: results of a nationwide mixed-methods study among inpatient care physicians in Germany. Infection. 2017;45(4):433-41.  https://doi.org/10.1007/s15010-017-0990-7  PMID: 28205159 
  39. Köck R, Kreienbrock L, van Duijkeren E, Schwarz S. Antimicrobial resistance at the interface of human and veterinary medicine. Vet Microbiol. 2017;200:1-5.  https://doi.org/10.1016/j.vetmic.2016.11.013  PMID: 27916320 
  40. Maier GS, Thorey F, Kolbow K, Lazovic D, Lühmann M, Ohnsorge J, et al. Livestock-assoziierter Methicillin-resistenter Staphylococcus aureus – Erhebung einer orthopädischen Fachklinik im Hochrisikogebiet Nord-West. [Livestock-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiological Data from an Orthopaedic Department in North-West Germany]. Z Orthop Unfall. 2017;155(3):304-9. PMID: 28431450 
  41. Nillius D, von Müller L, Wagenpfeil S, Klein R, Herrmann M. Methicillin-Resistant Staphylococcus aureus in Saarland, Germany: The Long-Term Care Facility Study. PLoS One. 2016;11(4):e0153030.  https://doi.org/10.1371/journal.pone.0153030  PMID: 27073899 
  42. Paget J, Aangenend H, Kühn M, Hautvast J, van Oorschot D, Olde Loohuis A, et al. MRSA Carriage in Community Outpatients: A Cross-Sectional Prevalence Study in a High-Density Livestock Farming Area along the Dutch-German Border. PLoS One. 2015;10(11):e0139589.  https://doi.org/10.1371/journal.pone.0139589  PMID: 26619190 
/content/10.2807/1560-7917.ES.2019.24.15.1800244
Loading

Data & Media loading...

Supplementary data

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error